Ovarian Cancer Clinical Trials
Writing About Experiences With Ovarian Cancer
This online study aims to understand whether writing about one's experiences with ovarian cancer may be beneficial for psychological and physical wellbeing in women with a history of ovarian cancer. Investigators are also intere...
Learn More
DOD Long-Term Survivors of Ovarian Cancer (LTSOC)
: Stages III and IV serum ovarian cancer are the most lethal of all gynecologic cancers; however, some advanced-stage ovarian cancer patients are long-term survivors. These patients may provide the key to long-term surviva...
Learn More
Quality of Life Associated With a Low-Risk Screening Program for Ovarian Cancer
The goal of this research study is to learn more about how women feel about an ovarian cancer screening program that involves getting a blood test to measure CA 125 levels. This includes finding out about women's quality of life and ...
Learn MoreLong Term Survivors in Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Other: Retrospective, cross-sectional descriptive analysis
Sponsor: University Medical Center Groningen
Recruiting - verified April 2017
Writing About Experiences With Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Behavioral: Writing about ovarian cancer
Sponsor: University of Maryland
Recruiting - verified May 2016
Biobehavioral and Sociodemographic Characteristics of Long Term Survivors of Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Behavioral: Questionnaire; Behavioral: Interview
Sponsors: M.D. Anderson Cancer Center; United States Department of Defense
Active, not recruiting - verified March 2017
Dual PETOvac - Dual Time PET/CT in the Preoperative Assessment of Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Other: PET/CT(3hours]
Sponsor: Odense University Hospital
Recruiting - verified October 2016
First Line Ovarian Cancer Treatment - Cohort Study
Condition: Epithelial Ovarian Cancer
Intervention: Drug: Bevacizumab
Sponsors: ARCAGY/ GINECO GROUP; Roche Pharma AG
Completed - verified March 2016
Veliparib and Topotecan for Relapsed Ovarian Cancer With Negative or Unknown BRCA Status
Condition: Ovarian Cancer
Interventions: Drug: Veliparib; Drug: Topotecan
Sponsors: Vejle Hospital; Abbott
Completed - verified June 2015
Influence of Chemotherapy on Gamma-delta T Cells in Patients With Epithelial Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Drug: Carboplatin and / or taxol chemotherapy
Sponsor: Rennes University Hospital
Withdrawn - verified August 2014
Hypodontia and Ovarian Cancer
Conditions: Ovarian Cancer; Hypodontia; Breast Cancer; Colon Cancer
Intervention:
Sponsors: University of Aarhus; Danish Cancer Society; Arvid-Nilsson Foundation
Unknown status - verified October 2013
Pelvic and Aortic-cava Lymphadenectomy Randomized for Ovarian Cancer
Condition: Ovarian Cancer
Intervention: Procedure: ovarian cancer surgery
Sponsor: Institut Cancerologie de l'Ouest
Recruiting - verified August 2016
Short Non-coding RNA Biomarkers of Predisposition to Ovarian Cancer
Condition: Ovarian Cancer
Intervention:
Sponsor: University of Virginia
Unknown status - verified December 2014
Motion Correction in Dynamic Contrast Enhanced Magnetic Resonance Imaging (MRI) in Ovarian Cancer: A Pilot Study
Condition: Ovarian Cancer
Intervention: Procedure: DCE-MRI scans
Sponsor: Memorial Sloan Kettering Cancer Center
Completed - verified October 2013
Prostaglandin Metabolite in Urine Samples From Patients With Ovarian Cancer
Condition: Ovarian Cancer
Interventions: Genetic: protein expression analysis; Other: immunohistochemistry
Sponsors: Vanderbilt-Ingram Cancer Center; National Cancer Institute (NCI)
Completed - verified April 2013